Killing effect of coexpressing cytosine deaminase and thymidine kinase on rat vascular smooth muscle cells

Chinese Medical Journal

Volumn 117, Issue 10, 2004, Pages 1464-1470

  Cao, Hui Qing ^a   Meng, Xian Min ^a   Liu, Dong Qing ^a   Zhao, Xiu Wen ^a   Ding, Jin Feng ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Coexpression; Suicide genes; Vascular smooth muscle cells

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CYTOSINE DEAMINASE; FLUCYTOSINE; FLUORESCENT DYE; GANCICLOVIR; GENOMIC DNA; TETRAZOLIUM; THYMIDINE KINASE;

AGAR GEL ELECTROPHORESIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL CULTURE; CELL DEATH; CELL KILLING; CLINICAL OBSERVATION; CONTROLLED STUDY; CYTOMEGALOVIRUS; DNA CLEAVAGE; DNA PROBE; DRUG CYTOTOXICITY; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC RECOMBINATION; HERPES SIMPLEX VIRUS; NONHUMAN; POLYMERASE CHAIN REACTION; RAT; SMOOTH MUSCLE FIBER; STATISTICAL SIGNIFICANCE; SUICIDE GENE; VASCULAR SMOOTH MUSCLE; VIRAL GENE DELIVERY SYSTEM; VIRUS GENOME; VIRUS RECOMBINANT; WESTERN BLOTTING;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELLS, CULTURED; CYTOSINE DEAMINASE; FLOW CYTOMETRY; GENE THERAPY; MUSCLE, SMOOTH, VASCULAR; POLYMERASE CHAIN REACTION; RATS; RATS, SPRAGUE-DAWLEY; THYMIDINE KINASE;

EID: 8844281516     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Yang X. Imaging of vascular gene therapy. Radiology 2003; 228:36-49.
2. Yonemitsu Y, Komori K, Sueishi K, et al. Gene therapy in vascular surgery comes of age. Surgery 2002;131:261-268.
3. Spencer DM. Developments in suicide genes for preclinical and clinical applications. Curr Opin Mol Ther 2000;2:433-440.
4. Harrell RL, Rajanayagam S, Doanes AM, et al. Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation 1997;96:621-627.
5. Metz MZ, Pichler A, Kuchler K, et al. Construction and characterization of single-transcript tricistronic retroviral vectors using two internal ribosome entry sites. Somat Cell Mol Genet 1998;24:53-69.
6. De Felipe P, Izquierdo M. Tricistronic and tetracistronic retroviral vectors for gene transfer. Hum Gene Ther 2000;11: 1921-1931.
7. Xie Y, Gilbert JD, Kim JH, et al. Efficacy of adenovirus-mediated CD/5-FC and HSV-1 thymidine kinase/ganciclovir suicide gene therapies concomitant with p53 gene therapy. Clin Cancer Res 1999;5:4224-4232.
8. Chang JW, Lee H, Kim E, et al. Combined antitumor effects of an adenoviral cytosine deaminase/thymidine kinase fusion gene in rat C6 glioma. Neurosurgery 2000;47:931-938.
9. Von der Leyen HE, Gibbons GH, Morishita R, et al. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sci U S A 1995;92:1137-1141.
10. Varenne O, Sinnaeve P, Gillijns H, et al. Percutaneous gene therapy using recombinant adenoviruses encoding human herpes simplex virus thymidine kinase, human PAI-1, and human NOS3 in balloon-injured porcine coronary arteries. Hum Gene Ther 2000;11:1329-1339.
11. Harrell RL, Rajanayagam S, Doanes AM, et al. Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase. Circulation 1997;96:621-627.